 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
2-12-2019
Insider Buy |
Ernest Mario
|
$89.99
CAGR »
|
$179,980.00
2,000 shares |
8-7-2018
Insider Buy |
John H. Weiland
|
$89.73
CAGR »
|
$500,250.33
5,575 shares |
5-9-2018
Insider Buy |
Mark J. Alles
CEO, CHAIRMAN OF BOARD |
$82.60
CAGR »
|
$99,784.42
1,208 shares |
2-8-2018
Insider Buy |
Mark J. Alles
See Remarks |
$91.90
CAGR »
|
$299,594.00
3,260 shares |
3-3-2016
Insider Buy |
Michael W. Bonney
Director |
$103.01
CAGR »
|
$206,028.00
2,000 shares |
5-29-2013
Insider Buy |
Ernest Mario
Director |
$123.72
CAGR »
|
$123,724.80
1,000 shares |
2-4-2013
Insider Buy |
Rodman L. Drake
Director |
$98.50
CAGR »
|
$39,399.04
400 shares |
6-22-2012
Insider Buy |
James J. Loughlin
Director |
$60.29
CAGR »
|
$36,174.00
600 shares |
5-21-2012
Insider Buy |
Jacqualyn A. Fouse
see remarks |
$68.92
CAGR »
|
$68,920.00
1,000 shares |
5-4-2012
Insider Buy |
Rodman L. Drake
Director |
$69.87
CAGR »
|
$34,935.00
500 shares |
4-27-2012
Insider Buy |
Rodman L. Drake
Director |
$72.77
CAGR »
|
$58,219.00
800 shares |
12-5-2011
Insider Buy |
Ernest Mario
Director |
$61.35
CAGR »
|
$122,700.00
2,000 shares |
11-2-2011
Insider Buy |
Ernest Mario
Director |
$63.00
CAGR »
|
$126,000.00
2,000 shares |
11-1-2011
Insider Buy |
Jacqualyn A. Fouse
Chief Financial Officer |
$63.92
CAGR »
|
$63,915.40
1,000 shares |
10-31-2011
Insider Buy |
Rodman L. Drake
Director |
$64.69
CAGR »
|
$32,345.60
500 shares |
8-19-2011
Insider Buy |
Rodman L. Drake
Director |
$54.74
CAGR »
|
$27,369.95
500 shares |
8-5-2011
Insider Buy |
Jacqualyn A. Fouse
Chief Financial Officer |
$55.75
CAGR »
|
$55,750.00
1,000 shares |
8-1-2011
Insider Buy |
Jacqualyn A. Fouse
Chief Financial Officer |
$59.47
CAGR »
|
$118,940.00
2,000 shares |
8-1-2011
Insider Buy |
Rodman L. Drake
Director |
$58.54
CAGR »
|
$29,267.70
500 shares |
6-14-2011
Insider Buy |
Jacqualyn A. Fouse
Chief Financial Officer |
$58.26
CAGR »
|
$116,512.00
2,000 shares |
3-15-2011
Insider Buy |
Ernest Mario
Director |
$53.33
CAGR »
|
$133,319.75
2,500 shares |
1-31-2011
Insider Buy |
Ernest Mario
Director |
$51.58
CAGR »
|
$515,772.00
10,000 shares |
Also See: Institutional Holders of CELG
Also See: SEC filings
Below we present the annualized performance delivered by Celgene stock since 2-12-2019 (the date of the most recent
insider purchase). The performance of the investment from the time Celgene insider buying occurred is the ultimate
test of whether insiders were right about CELG being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/13/2019 |
|
| End date: |
11/20/2019 |
|
| Start price/share: |
$89.74 |
|
| End price/share: |
$108.24 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
20.62% |
|
| Annualized Gain: |
26.87% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$12,062.00 |
|
| Years: |
0.77 |
|
Celgene Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Celgene insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CELG
|
|
Free CELG Email Alerts:
